BE/BC OB/Gyn is needed for northern California close to the Napa Valley and San Francisco. OB/Gyn Hospitalist program in place. Emergency Department call coverage is not required. This practice offers...

Commenting on the new Human Fertilisation and Embryology Act, Director of Policy and Campaigns, Robert Meadowcroft, said: "The Muscular Dystrophy Campaign wholeheartedly welcomes the passing into law of the Human Fertilisation and Embryology Act. The new legislation creates the framework in which vital progress can be made into research of devastating and life-limiting conditions such as muscular dystrophy.

A nationwide US study found that babies conceived with Assisted Reproductive Technology (ART), such as in vitro fertilization (IVF) were between 2 and 4 times more likely to be born with certain defects than babies conceived naturally. The study was conducted by researchers at the US Centers for Disease Control and Prevention (CDC) and was published early online in the journal Human Reproduction on 16 November.

A 39-year old woman who had the world's first whole ovary transplant gave birth to a healthy daughter in a private London hospital last week after undergoing pioneering new treatment developed in the US that allowed her to receive an ovary donated by her twin sister and then conceive naturally, according to a BBC News report.

Researchers from Brigham & Women's Hospital in Boston today presented data demonstrating that women undergoing In Vitro Fertilization (IVF) and using either vaginally-administered progesterone gel (CRINONEŽ 8%) or progesterone injected intramuscularly for luteal phase supplementation, reported no difference in ongoing pregnancy rates when they experienced luteal phase bleeding (LPB). LPB is defined as any bleeding or spotting between embryo transfer and first pregnancy test.

New laws that will help maintain the UK's position as a world leader in embryo research, enable scientists to investigate cures for serious illnesses such as Parkinson's disease and regulate assisted reproductive treatments, received Royal Assent today. The new Human Fertilisation and Embryology Act updates the 1990 law to ensure that it is fit for purpose in the 21st Century and keeps the UK at the forefront of developments in treatment and research.

Laura Witjens, Chair of the National Gamete Donation Trust said: "It is of great concern to the National Gamete Donation Trust that current inefficiencies and inconsistencies in sperm donor recruitment and management mean that patients are not given the best chance. Our experience is that dedicated potential sperm donors are lost on a regular basis because of insufficient care or lack of access.